针对癌症中的阿克特信号通路:分子机制和治疗干预的进展
Premila D Leiphrakpam1,2, Rishi Batra3, Laura Tenner4
1College of Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Frontiers in bioscience (Landmark edition)
|December 6, 2025
概括
该Akt信号通路调节细胞生长和存活. 它在癌症中的失调驱动瘤的进展,使阿克特成为新型癌症治疗的关键目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 阿克特/蛋白激酶B (PKB) 途径是酸酸3-激酶 (PI3K) 下游的一个关键信号轴.
- 它调节了基本的细胞过程,包括生长,增殖,亡,生存和迁移.
- 在癌症中,Akt路径组件的平衡被破坏,促进瘤的发展.
研究的目的:
- 审查Akt信号通路在癌症中的作用.
- 讨论当前的Akt向治疗剂及其局限性.
- 探索阿克特向癌症治疗的未来方向.
主要方法:
- 在癌症中Akt信号的文献综述.
- 对当前阿克特向药物的分析及其临床疗效.
- 讨论分子机制和治疗策略.
主要成果:
- 由于突变,Akt通路在各种癌症中经常失调.
- 目前的阿克特抑制剂看起来有前途,但面临着耐药性和毒性等挑战.
- 针对Akt的下游影响者,可能会提供替代治疗途径.
结论:
- 了解Akt路径失调对于有效的癌症治疗至关重要.
- 新型阿克特向药物和组合疗法的开发正在进行中.
- 未来的研究应该专注于克服治疗局限性,并在Akt途径中探索新的目标.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.8K
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
8.3K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Canonical Wnt Signaling Pathway
10.3K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K
